BioCentury | Nov 19, 2015
Product R&D

A solid move

...2010 by Lund researchers Thoas Fioretos, Marcus Järås and Kjell Sjöström with the help of Lund University Bioscience AB...
...AB, Lund, Sweden Kyowa Hakko Kirin Co. Ltd. (Tokyo:4151), Tokyo, Japan Lund University, Lund, Sweden Lund University Bioscience AB...
BioCentury | Jul 15, 2013
Financial News

Cantargia financial update

...million) in a series A round, bringing the total raised to SEK11.3 million ($1.7 million). Lund University Bioscience AB...
BioCentury | Jan 28, 2013
Emerging Company Profile

MD Pharma AB: Dialing down autophagy

...autophagy Disease focus: Musculoskeletal Clinical status: Discovery Founded: 2011 by Madeleine Durbeej-Hjalt, Virginie Carmignac and Lund University Bioscience AB...
...collaborators: Lund University Corporate partners: None Number of employees: 1 Funds raised: €300,000 ($399,000) Investors: Lund University Bioscience AB...
BioCentury | Jan 30, 2012
Emerging Company Profile

Cantargia: Stemming CML

...to in-license other projects. Svedberg said Cantargia has sufficient financial support from its sole investor, Lund University Bioscience AB...
...Co. (NYSE:BMY), New York, N.Y. Cantargia AB , Lund, Sweden Lund University , Lund, Sweden Lund University Bioscience AB...
...Cancer Clinical status: Lead optimization Founded: 2010 by Thoas Fioretos, Marcus Jaras, Kjell Sjostrom and Lund University Bioscience AB...
BioCentury | Apr 4, 2011
Emerging Company Profile

XImmune: Self-help Peptides

...do by early 2012, and would consider partnering out the others, according to Malmborg Hager. Lund University Bioscience AB...
...and Institutions Mentioned Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Lund University , Lund, Sweden Lund University Bioscience AB...
...University Corporate partners: None Number of employees: 1 Funds raised: €1 million ($1.5 million) Investors: Lund University Bioscience AB...
BioCentury | Feb 28, 2011
Financial News

Cantargia completes venture financing

...Lund, Sweden Business: Cancer Date completed: 1/3/11 Type: Venture financing Raised: SEK4.3 million ($638,981) Investor: Lund University Bioscience AB...
BioCentury | Jan 6, 2011
Strategy

LU Bio: Swedish hybrid

...A/S , Saint-Prex, Switzerland Karolinska Development AB , Solna, Sweden Lund University , Lund, Sweden Lund University Bioscience AB...
BioCentury | Sep 16, 2010
Cover Story

Homing in on CML stem cells

...declined to comment. Therapeutic directions Cantargia was formed by Fioretos, Marcus Järås, Kjell Sjöström and Lund University Bioscience AB...
...Cantargia AB , Lund, Sweden Innovagen AB , Lund, Sweden Lund University , Lund, Sweden Lund University Bioscience AB...
BioCentury | Jul 5, 2010
Emerging Company Profile

ProNoxis: Promoting ROS

...periphery in mice, but mutant NCF1 does not, resulting in increased arthritis severity. Seed investors Lund University Bioscience AB...
...Companies and Institutions Mentioned Karolinska Development AB , Solna, Sweden Lund University , Lund, Sweden Lund University Bioscience AB...
...of NADPH oxidase 2 (NOX2) Disease focus: Autoimmune Clinical status: Lead selection Founded: 2009 by Lund University Bioscience AB...
BioCentury | Jul 6, 2009
Company News

Lund University cardiovascular news

...The university and Lund University Bioscience AB, an early stage investor, formed newco Auril AB to develop a compound...
Items per page:
1 - 10 of 13
BioCentury | Nov 19, 2015
Product R&D

A solid move

...2010 by Lund researchers Thoas Fioretos, Marcus Järås and Kjell Sjöström with the help of Lund University Bioscience AB...
...AB, Lund, Sweden Kyowa Hakko Kirin Co. Ltd. (Tokyo:4151), Tokyo, Japan Lund University, Lund, Sweden Lund University Bioscience AB...
BioCentury | Jul 15, 2013
Financial News

Cantargia financial update

...million) in a series A round, bringing the total raised to SEK11.3 million ($1.7 million). Lund University Bioscience AB...
BioCentury | Jan 28, 2013
Emerging Company Profile

MD Pharma AB: Dialing down autophagy

...autophagy Disease focus: Musculoskeletal Clinical status: Discovery Founded: 2011 by Madeleine Durbeej-Hjalt, Virginie Carmignac and Lund University Bioscience AB...
...collaborators: Lund University Corporate partners: None Number of employees: 1 Funds raised: €300,000 ($399,000) Investors: Lund University Bioscience AB...
BioCentury | Jan 30, 2012
Emerging Company Profile

Cantargia: Stemming CML

...to in-license other projects. Svedberg said Cantargia has sufficient financial support from its sole investor, Lund University Bioscience AB...
...Co. (NYSE:BMY), New York, N.Y. Cantargia AB , Lund, Sweden Lund University , Lund, Sweden Lund University Bioscience AB...
...Cancer Clinical status: Lead optimization Founded: 2010 by Thoas Fioretos, Marcus Jaras, Kjell Sjostrom and Lund University Bioscience AB...
BioCentury | Apr 4, 2011
Emerging Company Profile

XImmune: Self-help Peptides

...do by early 2012, and would consider partnering out the others, according to Malmborg Hager. Lund University Bioscience AB...
...and Institutions Mentioned Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Lund University , Lund, Sweden Lund University Bioscience AB...
...University Corporate partners: None Number of employees: 1 Funds raised: €1 million ($1.5 million) Investors: Lund University Bioscience AB...
BioCentury | Feb 28, 2011
Financial News

Cantargia completes venture financing

...Lund, Sweden Business: Cancer Date completed: 1/3/11 Type: Venture financing Raised: SEK4.3 million ($638,981) Investor: Lund University Bioscience AB...
BioCentury | Jan 6, 2011
Strategy

LU Bio: Swedish hybrid

...A/S , Saint-Prex, Switzerland Karolinska Development AB , Solna, Sweden Lund University , Lund, Sweden Lund University Bioscience AB...
BioCentury | Sep 16, 2010
Cover Story

Homing in on CML stem cells

...declined to comment. Therapeutic directions Cantargia was formed by Fioretos, Marcus Järås, Kjell Sjöström and Lund University Bioscience AB...
...Cantargia AB , Lund, Sweden Innovagen AB , Lund, Sweden Lund University , Lund, Sweden Lund University Bioscience AB...
BioCentury | Jul 5, 2010
Emerging Company Profile

ProNoxis: Promoting ROS

...periphery in mice, but mutant NCF1 does not, resulting in increased arthritis severity. Seed investors Lund University Bioscience AB...
...Companies and Institutions Mentioned Karolinska Development AB , Solna, Sweden Lund University , Lund, Sweden Lund University Bioscience AB...
...of NADPH oxidase 2 (NOX2) Disease focus: Autoimmune Clinical status: Lead selection Founded: 2009 by Lund University Bioscience AB...
BioCentury | Jul 6, 2009
Company News

Lund University cardiovascular news

...The university and Lund University Bioscience AB, an early stage investor, formed newco Auril AB to develop a compound...
Items per page:
1 - 10 of 13